Uromedica Overview

  • Founded
  • 1997
Founded
  • Status
  • Private
  • Employees
  • 29
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $1.85M
Latest Deal Amount
  • Investors
  • 1

Uromedica General Information

Description

Developer of medical devices designed to treat stress urinary incontinence. The company's device is a minimally invasive adjustable balloon that can be implanted on either side of the urinary bladder neck and does not require any patient manipulation, enabling patients to overcome their continence issues resulting from intrinsic sphincter deficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 1840 Berkshire Lane North
  • Plymouth, MN 55441
  • United States
+1 (763) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Uromedica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 15-Jan-2019 $1.85M 0000 000.00 Completed Generating Revenue
4. Later Stage VC 02-Jan-2012 0000 000.00 Completed Generating Revenue
3. Later Stage VC (Series A) 24-Oct-2007 00.00 000.00 000.00 Completed Generating Revenue
2. Angel (individual) 08-Mar-2005 $1000K $4.9M Completed Generating Revenue
1. Angel (individual) 05-Apr-2004 $3.9M $3.9M Completed Generating Revenue
To view Uromedica’s complete valuation and funding history, request access »

Uromedica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Uromedica’s complete cap table history, request access »

Uromedica Patents

Uromedica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020221379-A1 Apparatus for monitoring implantable device for urinary continence Pending 14-Feb-2019 000000000
CA-3130302-A1 Apparatus for monitoring implantable device for urinary continence Pending 14-Feb-2019 000000000
US-20210251737-A1 Method and apparatus for monitoring implantable device for urinary continence Pending 14-Feb-2019 000000000
US-20210251736-A1 Method and apparatus for monitoring implantable device for urinary continence Pending 14-Feb-2019 000000000
US-20200261200-A1 Method and apparatus for monitoring implantable device for urinary continence Pending 14-Feb-2019 A61F2/004
To view Uromedica’s complete patent history, request access »

Uromedica Executive Team (3)

Name Title Board Seat Contact Info
Timothy Cook Co-Founder, Chief Executive Officer, President and Board Member
John Reineck Chief Financial Officer
John Burton Co-Founder and Board Member
To view Uromedica’s complete executive team members history, request access »

Uromedica Board Members (8)

Name Representing Role Since
Alex Gross Self Board Member 000 0000
David Booth Self Board Member 000 0000
Douglas Glader Self Board Member 000 0000
John Burton Uromedica Co-Founder and Board Member 000 0000
John Haveman Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Uromedica Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Uromedica Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Medtronic (Other Healthcare Technology Systems) Corporation Minority 000 0000 000000 0
To view Uromedica’s complete investors history, request access »